1B1

HC SURGICAL SPECIALISTSLIMITED

1B1.SG hcsurgicalspecialists.com
0.35
+0.00 (+0.00%)
SGD · SG
52-week range
0.32
0.40
Trading at 37% of the 52-week range
Market Cap
53.68M
P/E Ratio
7.00
Forward P/E
0.00
Book Value
0.14
Div. Yield
6.00%
% Institutions
1.11%
% Insiders
82.73%

1 Year

+9.2%

3 Year

+14.9%

10 Year

-1.9%
Description

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services. In addition, the company provides orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, wounds/lumps, tenosynovitis, tunnel syndrome, bumps, joint replacement, arthroscopic surgery, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, fractures, and orthobiologic injections. Further, it provides home care services, which include medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; health screening, management of acute and chronic conditions, and pre-employment check-up; public health preparedness clinic scheme, swab and send home program, community health assist scheme, and COVID-19 swab test services. Additionally, the company offers diagnostic tests that comprise blood tests, X-Rays, ultrasound, CT scans, and MRIs. HC Surgical Specialists Limited was incorporated in 2015 and is based in Singapore.

Company Information

Company Name
HC SURGICAL SPECIALISTSLIMITED
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
SG
ISIN: SG1DC2000004
Currency: SGD
Full Time Employees: 0
Phone: 65 6205 0345
Fiscal Year End: May
Description:

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services. In addition, the company provides orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, wounds/lumps, tenosynovitis, tunnel syndrome, bumps, joint replacement, arthroscopic surgery, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, fractures, and orthobiologic injections. Further, it provides home care services, which include medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; health screening, management of acute and chronic conditions, and pre-employment check-up; public health preparedness clinic scheme, swab and send home program, community health assist scheme, and COVID-19 swab test services. Additionally, the company offers diagnostic tests that comprise blood tests, X-Rays, ultrasound, CT scans, and MRIs. HC Surgical Specialists Limited was incorporated in 2015 and is based in Singapore.

Address:

233 River Valley Road, Singapore, Singapore, 238291

People

Directors & Officers

Name Title Year Born
Dr. Sieu Min Heah FAMS Surgen, FRCSEd, MB BCh CEO & Executive Director 1964
Dr. Kok Hoong Chia FAMS G, FRCSEd, MBBS Medical Director & Executive Director 1960
Ms. Soo Ling Ong Chief Financial Officer 1979
Ms. Josephine Tio Melissa Chief Operating Officer NA
Mr. Gary Ng Head of the Internal Audit NA
Ms. Hui Theng Lee Chief Nursing Officer NA
Ms. Moi Heyang Lin ACIS Joint Company Secretary NA
Ms. Pei Chan Tang ACIS Joint Company Secretary NA

Financial Highlights

Market Cap: $53.68M
EBITDA: $5.37M
P/E Ratio: $7.00
Book Value: $0.14
Dividend/Share: $0.02
Dividend Yield: 6.00%
Earnings/Share: $0.05
Profit Margin: 35.40%
Operating Margin: 23.80%
ROA (TTM): 10.32%
ROE (TTM): 34.81%
Revenue (TTM): $19.73M
Revenue/Share (TTM): $0.13
Earnings Growth (YOY): -40.40%
Revenue Growth (YOY): 6.30%

Valuation Metrics

Enterprise Value: $48.29M
Trailing P/E: 7.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 153.38M
Shares Float: 24.51M
% Insiders: 82.73%
% Institutions: 1.11%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$19.11M
Cost of Goods Sold
adjust
$-3.00M
Gross Profit
subtotal
$16.11M
SG&A
adjust
$-413.00K
Other Operating Expense
adjust
$-11.62M
Operating Income
subtotal
$7.08M
Other / Non-Operating Items
adjust
$1.36M
Net Income
subtotal
$8.44M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about 1B1.SG!